Antihypertensive withdrawal for the prevention of cognitive decline-Reference-Cited by-同舟云学术

Antihypertensive withdrawal for the prevention of cognitive decline

Published:2016-11-01 Issue:11 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Jongstra Susan¹,Harrison Jennifer K²,Quinn Terry J³,Richard Edo⁴

Affiliation:

1. University of Amsterdam; Department of Neurology, Academic Medical Centre; Meibergdreef 9 Amsterdam Netherlands 1105 AZ

2. University of Edinburgh; Centre for Cognitive Ageing and Cognitive Epidemiology and the Alzheimer Scotland Dementia Research Centre; Department of Geriatric Medicine, The Royal Infirmary of Edinburgh, Room S1642 51 Little France Crescent Edinburgh UK EH16 4SB

3. University of Glasgow; Institute of Cardiovascular and Medical Sciences; Walton Building Glasgow Royal Infirmary Glasgow UK G4 0SF

4. Radboud University Nijmegen Medical Center; Department of Neurology; Nijmegen Netherlands

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011971.pub2/epdf/full

Reference134 articles.

1. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial;Bath;Lancet,2015

2. Scutt P Woodhouse L Krishnan K Bath P Continue versus withdrawal of pre-stroke antihypertensive therapy in the first week after acute stroke: a randomised controlled trial International Journal of Stroke 2014

3. Effect of discontinuation of antihypertensive treatment in elderly people on cognitive functioning - the DANTE Study Leiden: a randomized clinical trial;Moonen;JAMA Internal Medicine,2015

4. Addition of non-pharmacological methods of treatment in patients on antihypertensive drugs: results of previous medication, laboratory tests and life quality;Aberg;Journal of Internal Medicine,1989

5. Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation;Journal of the International Society of Hypertension,2001

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deprescribing: An umbrella review;Acta Pharmaceutica;2024-05-30

2. The efficacy and safety of post-stroke cognitive impairment therapies: an umbrella review;Frontiers in Pharmacology;2023-08-24

3. Angiotensin-II stimulating vs. inhibiting antihypertensive drugs and the risk of Alzheimer's disease or related dementia in a large cohort of older patients with colorectal cancer;Frontiers in Cardiovascular Medicine;2023-05-05

4. A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function in Geriatric Patients;Drugs & Aging;2022-10-26

5. Impact of arterial hypertension and its management strategies on cognitive function and dementia: a comprehensive umbrella review;Minerva Cardiology and Angiology;2022-05